Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Vera Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 173 | 4 | 178 | +9 |
| Shares | 53.5M | 116.6K | 62.9M | +9.51M (+17.8%) |
| Value | $2.37B | $5.15M | $2.66B | +$300.6M (+12.7%) |
4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Vera Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (23)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| ExodusPoint Capital Management, LP | 153,596 | $6.79M |
| Driehaus Capital Management LLC | 106,815 | $4.72M |
| Voloridge Investment Management, LLC | 73,141 | $3.23M |
| Squarepoint Ops LLC | 70,416 | $3.11M |
| Jane Street Group, LLC | 46,420 | $2.05M |
| Point72 (DIFC) Ltd | 43,789 | $1.94M |
| HRT Financial LP | 32,239 | $1.42M |
| Y-Intercept (Hong Kong) Ltd | 30,911 | $1.37M |
| Hudson Bay Capital Management LP | 30,500 | $1.35M |
| Harvest Investment Services, LLC | 16,313 | $721.0K |
| Bayesian Capital Management, LP | 11,722 | $518.1K |
| FORA Capital, LLC | 10,622 | $469.5K |
| Point72 Asia (Singapore) Pte. Ltd. | 9,407 | $415.8K |
| Franklin Resources Inc | 8,746 | $368.9K |
| AlphaCentric Advisors LLC | 7,500 | $331.5K |
| Two Sigma Advisers, LP | 6,000 | $265.2K |
| Acadian Asset Management LLC | 2,185 | $96.0K |
| Catalyst Funds Management Pty Ltd | 1,200 | $53.0K |
| SRS Capital Advisors, Inc. | 81 | $3.58K |
| Bessemer Group Inc | 35 | $2.00K |
| Aster Capital Management (DIFC) Ltd | 44 | $1.95K |
| Capital Performance Advisors LLP | 11 | $486 |
| The PNC Financial Services Group, Inc. | 5 | $221 |
Not filed for Q4 2024 yet (4)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 46,547 | $2.06M |
| Portman Ltd | 32,795 | $1.45M |
| Chartwell Investment Partners, LLC | 19,172 | $847.0K |
| Raymond James Financial Services Advisors, Inc. | 18,101 | $800.1K |